Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Operating Leases: 2019-2024

Historic Operating Leases for Surgery Partners (SGRY) over the last 6 years, with FY2024 value amounting to $1.1 billion.

  • Surgery Partners' Operating Leases rose 1570.29% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 1570.29%. This contributed to the annual value of $1.1 billion for FY2024, which is 1547.8% up from last year.
  • As of FY2024, Surgery Partners' Operating Leases stood at $1.1 billion, which was up 1547.8% from $980.1 million recorded in FY2023.
  • Surgery Partners' Operating Leases' 5-year high stood at $1.1 billion during FY2024, with a 5-year trough of $621.3 million in FY2020.
  • Its 5-year average for Operating Leases is $869.4 million, with a median of $893.6 million in 2022.
  • Its Operating Leases has fluctuated over the past 5 years, first skyrocketed by 827.81% in 2020, then surged by 2405.94% in 2022.
  • Over the past 5 years, Surgery Partners' Operating Leases (Annual) stood at $621.3 million in 2020, then rose by 15.93% to $720.3 million in 2021, then grew by 24.06% to $893.6 million in 2022, then rose by 9.68% to $980.1 million in 2023, then grew by 15.48% to $1.1 billion in 2024.
  • Its Operating Leases stands at $1.1 billion for FY2024, versus $980.1 million for FY2023 and $893.6 million for FY2022.